Masayoshi Kumai

Construction of a Risk Prediction Model of Extended Release Oxycodone Tablet-Induced Nausea and Clarification of Predictive Factors.

Y. Takekuma, S. Imai, Takehiro Yamada, 2021, Biological & pharmaceutical bulletin.

Serotonin Syndrome Developing Immediately after the Initiation of Low-Dose Methadone Therapy: A Case Report

Y. Takekuma, Takehiro Yamada, M. Sugawara, 2020, Case Reports in Oncology.

Two Cases of Effective Combined Treatment with a Histamine H1 Receptor Antagonist and Perospirone for Intractable Nausea and Vertigo Induced by Opioid Treatment

S. Fukuda, A. Homma, T. Sakashita, 2012 .

[Efficacy Survey of Naldemedine in the Poor-performance Status Group].

Y. Takekuma, S. Imai, Shintaro Kato, 2022, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.